FDA Inspection 1229261 — Northeast Laboratories, Inc.
The FDA completed an inspection of Northeast Laboratories, Inc. on January 11, 2024 in Rocky Hill, CT. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- January 11, 2024
- Fiscal Year
- 2024
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Rocky Hill, CT (United States)